Notice of General Meeting and Proxy Form
Released
Released
Announcement PDF
Kali Metals Limited
ACN 653 279 371
Notice of General Meeting
The General Meeting of the Company will be held as follows:
Time and date: 10:00 AM (AWST) on Tuesday, 31 March 2026
In-person: Ground Floor, 34 Colin Street, West Perth, WA 6005
The Notice of General Meeting should be read in its entirety. If Shareholders are in doubt as to how
to vote, they should seek advice from their accountant, solicitor or other suitably qualified
professional advisor prior to voting.
Should you wish to discuss any matter, please do not hesitate to contact the Company
Secretary by email via admin@kalimetals.com.au.
Shareholders are urged to vote by lodging the Proxy Form
Page 1
Kali Metals Limited
ACN 653 279 371
(Company)
Notice of General Meeting
Notice is hereby given that a general meeting of Shareholders of Kali Metals Limited (Company) will be
held at Ground Floor, 34 Colin Street, West Perth, WA 6005, on Tuesday, 31 March 2026 at 10:00 am
(AWST) (Meeting).
The Explanatory Memorandum provides additional information on matters to be considered at the
Meeting. The Explanatory Memorandum and the Proxy Form form part of the Notice.
The Directors have determined pursuant to regulation 7.11.37 of the Corporations Regulations 2001
(Cth) that the persons eligible to vote at the Meeting are those who are registered as Shareholders on
Sunday, 29 March 2026 at 10:00 am (AWST).
Terms and abbreviations used in the Notice are defined in Schedule 1.
1. Agenda
Resolution 1 – Ratification of issue of Placement Shares
To consider and, if thought fit, to pass with or without amendment, each as a separate
ordinary resolution the following:
‘That, pursuant to and in accordance with Listing Rule 7.4 and for all other purposes,
Shareholders ratify the issue of:
(a) 23,068,830 Placement Shares under Listing Rule 7.1; and
(b) 15,403,393 Placement Shares under Listing Rule 7.1A,
on the terms and conditions in the Explanatory Memorandum.’
Resolution 2 – Approval to issue Director Placement Shares
To consider and, if thought fit, to pass with or without amendment, each as a separate
ordinary resolution the following:
‘That, pursuant to and in accordance with Listing Rule 10.11, section 195(4) of the
Corporations Act and for all other purposes, Shareholders approve the issue of up to 527,778
Director Placement Shares to the Participating Directors (or their respective nominee/s) as
follows:
(a) up to 111,111 Director Placement Shares to Luke Reinehr;
(b) up to 138,889 Director Placement Shares to Graeme Sloan; and
(c) up to 277,778 Director Placement Shares to Paul Adams,
(or their respective nominee/s) on the terms and conditions in the Explanatory Memorandum.’
Page 2
3454-2567-2519, v. 4
Resolution 3 – Approval to issue Broker Options
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution
the following:
‘That, pursuant to and in accordance with Listing Rule 7.1 and for all other purposes,
Shareholders approve the issue of up to 5,000,000 Broker Options to the Lead Manager (or
its nominee/s), on the terms and conditions in the Explanatory Memorandum.’
Resolution 4 – Ratification of agreement to issue SQM Consideration
Shares
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution
the following:
‘That, pursuant to and in accordance with Listing Rule 7.4 and for all other purposes,
Shareholders ratify the agreement to issue up to 816,713 SQM Consideration Shares, on the
terms and conditions in the Explanatory Memorandum.’
2. Voting exclusion
Pursuant to the Listing Rules, the Company will disregard any votes cast in favour of the
relevant Resolution by or on behalf of the following persons:
Resolution Disregard any votes cast in favour:
Resolution 1(a)
and Resolution
1(b)
by or on behalf of any person who participated in the issue of the
Placement Shares, or any of their respective associates, or their
nominees.
Resolution 2(a) by or on behalf of Luke Reinehr (or his nominee/s), and any other
person who will obtain a material benefit as a result of the issue of
these Director Placement Shares (except a benefit solely by reason of
being a Shareholder), or any of their respective associates, or their
nominees.
Resolution 2(b) by or on behalf of Graeme Sloan (or his nominee/s), and any other
person who will obtain a material benefit as a result of the issue of
these Director Placement Shares (except a benefit solely by reason of
being a Shareholder), or any of their respective associates, or their
nominees.
Resolution 2(c) by or on behalf of Paul Adams (or his nominee/s), and any other
person who will obtain a material benefit as a result of the issue of
these Director Placement Shares (except a benefit solely by reason of
being a Shareholder), or any of their respective associates, or their
nominees.
Resolution 3 by or on behalf of the Lead Manager (or its nominee/s) and any
person who will obtain a material benefit as a result of the proposed
issue of the Broker Options (except a benefit solely by reason of being
a Shareholder) or any of their respective associates.
Resolution 4 by or on behalf of SQM, or any of its associates or nominee/s.
Page 3
3454-2567-2519, v. 4
The above voting exclusions do not apply to a vote cast in favour of the relevant Resolution
by:
(a) a person as proxy or attorney for a person who is entitled to vote on that Resolution,
in accordance with directions given to the proxy or attorney to vote on that Resolution
in that way;
(b) the Chair as proxy or attorney for a person who is entitled to vote on that Resolution,
in accordance with a direction given to the Chair to vote on that Resolution as the
Chair decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on
behalf of a beneficiary provided the following conditions are met:
(i) the beneficiary provides written confirmation to the holder that the beneficiary
is not excluded from voting, and is not an associate of a person excluded
from voting, on the relevant Resolution; and
(ii) the holder votes on that Resolution in accordance with directions given by the
beneficiary to the holder to vote in that way.
BY ORDER OF THE BOARD
Silfia Morton
Company Secretary
Kali Metals Limited
Dated: 25 February 2026
Page 4
Kali Metals Limited
ACN 653 279 371
(Company)
Explanatory Memorandum
1. Introduction
The Explanatory Memorandum has been prepared for the information of Shareholders in
connection with the business to be conducted at the Meeting to be held at Ground Floor, 34
Colin Street, on Tuesday, 31 March 2026 at 10:00 am (AWST).
The Explanatory Memorandum forms part of the Notice which should be read in its entirety.
The Explanatory Memorandum contains the terms and conditions on which the Resolutions
will be voted.
The Explanatory Memorandum includes the following information to assist Shareholders in
deciding how to vote on the Resolutions:
Section 2 Action to be taken by Shareholders
Section 3 Resolution 1 – Ratification of issue of Placement Shares
Section 4 Resolution 2 – Approval to issue Director Placement Shares
Section 5 Resolution 3 – Approval to issue Broker Options
Section 6 Resolution 4 – Ratification of agreement to issue SQM Consideration
Shares
Schedule 1 Definitions
Schedule 2 Terms and conditions of Broker Options
A Proxy Form is made available with this Notice.
Page 5
2. Action to be taken by Shareholders
Shareholders should read the Notice including the Explanatory Memorandum carefully before
deciding how to vote on the Resolutions.
2.1 Voting in person
To vote in person, attend the Meeting on the date and at the place set out above.
2.2 Voting by a corporation
A Shareholder that is a corporation may appoint an individual to act as its representative and
vote in person at the Meeting. The appointment must comply with the requirements of section
250D of the Corporations Act. The representative should bring to the Meeting evidence of
their appointment, including any authority under which it is signed.
2.3 Voting by proxy
A Proxy Form is made available with this Notice. This is to be used by Shareholders if they
wish to appoint a representative (a ‘proxy’) to vote in their place. All Shareholders are invited
and encouraged to attend the Meeting or, if they are unable to attend in person, complete the
Proxy Form to the Company in accordance with the instructions thereon. Lodgement of a
Proxy Form will not preclude a Shareholder from attending and voting at the Meeting in
person.
Please note that:
(a) a member of the Company entitled to attend and vote at the Meeting is entitled to
appoint a proxy;
(b) a proxy need not be a member of the Company; and
(c) a member of the Company entitled to cast two or more votes may appoint two proxies
and may specify the proportion or number of votes each proxy is appointed to
exercise, but where the proportion or number is not specified, each proxy may
exercise half of the votes.
The available Proxy Form provides further details on appointing proxies and lodging Proxy
Forms.
Section 250BB(1) of the Corporations Act provides that an appointment of a proxy may
specify the way the proxy is to vote on a particular resolution and, if it does:
(a) the proxy need not vote on a show of hands, but if the proxy does so, the proxy must
vote that way (i.e. as directed);
(b) if the proxy has 2 or more appointments that specify different ways to vote on the
resolution – the proxy must not vote on a show of hands;
(c) if the proxy is the Chair of the meeting at which the resolution is voted on – the proxy
must vote on a poll, and must vote that way (i.e. as directed); and
(d) if the proxy is not the Chair – the proxy need not vote on the poll, but if the proxy does
so, the proxy must vote that way (i.e. as directed).
Section 250BC of the Corporations Act provides that, if:
(a) an appointment of a proxy specifies the way the proxy is to vote on a particular
resolution at a meeting of the Company’s members;
Page 6
(b) the appointed proxy is not the chair of the meeting;
(c) at the meeting, a poll is duly demanded, or is otherwise required under section 250JA
on the resolution; and
(d) either the proxy is not recorded as attending the meeting or the proxy does not vote
on the resolution,
the Chair of the meeting is taken, before voting on the resolution closes, to have been
appointed as the proxy for the purposes of voting on the resolution at the meeting.
Your proxy voting instruction must be received by 10:00 am (AWST) on Sunday, 29 March
2026, being not later than 48 hours before the commencement of the Meeting.
2.4 Chair’s voting intentions
The Chair intends to exercise all available proxies in favour of all Resolutions, unless the
Shareholder has expressly indicated a different voting intention. In exceptional circumstances,
the Chair of the Meeting may change their voting intention on any Resolution, in which case
an ASX announcement will be made.
2.5 Submitting questions
Shareholders may submit questions in advance of the Meeting to the Company. Questions must
be submitted by emailing the Company Secretary at admin@kalimetals.com.au by no later than
five business days before the Meeting.
Shareholders will also have the opportunity to submit questions during the Meeting in respect
to the formal items of business. In order to ask a question during the Meeting, please follow
the instructions from the Chair.
The Chair will attempt to respond to the questions during the Meeting. The Chair will request
prior to a Shareholder asking a question that they identify themselves (including the entity
name of their shareholding and the number of Shares they hold).
Page 7
3. Resolution 1 – Ratification of issue of Placement Shares
3.1 General
On 6 February 2026, the Company announced that it had received firm commitments for a
placement to raise approximately $7 million (before costs) (Placement).
The Placement is comprised of the following two tranches:
(a) Tranche 1: the issue of 38,472,223 Shares (Placement Shares), comprising:
(i) 23,068,830 Placement Shares issued under Listing Rule 7.1; and
(ii) 15,403,393 Placement Shares issued under Listing Rule 7.1A;
(b) Tranche 2: the issue of up to 527,778 Shares (Director Placement Shares) to
Directors Luke Reinehr, Graeme Sloan and Paul Adams (the Participating
Directors), subject to receipt of Shareholder approval (the subject of Resolution 2(a)
to (c) (inclusive)).
On 17 February 2026, the Company issued the Placement Shares without prior Shareholder
approval using the Company’s available placement capacity under Listing Rules 7.1 and
7.1A. The Company confirms that the issue of the Placement Shares did not breach Listing
Rules 7.1 or 7.1A at the time of the agreement to issue the Placement Shares.
Argonaut Securities Pty Limited acted as sole lead manager, broker and bookrunner to the
Placement (Lead Manager). Subject to Shareholder approval, as partial consideration for the
provision of the lead managerial, broker and bookrunner services in connection with the
Placement, the Company has agreed to issue the Lead Manager (or its nominee/s) up to
5,000,000 Options on the terms and conditions set out in Schedule 2 (Broker Options), the
subject of Resolution 3. A summary of the Lead Manager Mandate is set out in Section 5.2
below.
Resolution 1(a) and Resolution 1(b) seek the approval of Shareholders pursuant to Listing
Rule 7.4 to ratify the issue of the Placement Shares.
3.2 Listing Rules 7.1, 7.1A and 7.4
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of
Equity Securities that a listed company can issue without the approval of its shareholders
over any 12-month period to 15% of the fully paid ordinary shares it had on issue at the start
of that period.
Under Listing Rule 7.1A, an eligible entity can seek approval from its members, by way of a
special resolution passed at its annual general meeting, to increase the 15% limit under
Listing Rule 7.1 by an additional 10% to 25%. The Company obtained this approval at its
2025 annual general meeting held on 12 November 2025.
The issue of the Placement Shares does not fit within any of the exceptions to Listing Rules
7.1 and 7.1A and, as it had not yet been approved by Shareholders, effectively uses up part
of the Company’s 15% placement capacity under Listing Rule 7.1 and 10% placement
capacity under Listing Rule 7.1A. This reduces the Company’s capacity to issue further Equity
Securities without Shareholder approval under those Listing Rules for the 12-month period
following the issue of the Placement Shares.
Listing Rule 7.4 provides an exception to Listing Rules 7.1 and 7.1A. It provides that where a
company in a general meeting ratifies the previous issue of securities made pursuant to
Listing Rules 7.1 and 7.1A (and provided that the previous issue did not breach Listing Rules
Page 8
7.1 and 7.1A), those securities will be deemed to have been made with shareholder approval
for the purposes of Listing Rule 7.1 and 7.1A.
The effect of Shareholders passing Resolution 1(a) and Resolution 1(b) will be to allow the
Company to retain the flexibility to issue Equity Securities in the future up to the 15%
placement capacity set out in Listing Rule 7.1 and the 10% additional placement capacity set
out in Listing Rule 7.1A, without the requirement to obtain prior Shareholder approval.
If Resolution 1(a) is passed, 23,068,830 Placement Shares will be excluded in calculating the
Company’s 15% limit in Listing Rule 7.1, effectively increasing the number of Equity
Securities it can issue without Shareholder approval over the 12-month period following the
issue date.
If Resolution 1(a) is not passed, 23,068,830 Placement Shares will continue to be included in
the Company’s 15% limit under Listing Rule 7.1, effectively decreasing the number of Equity
Securities the Company can issue or agree to issue without obtaining prior Shareholder
approval, to the extent of 23,068,830 Equity Securities for the 12-month period following the
issue of those Placement Shares.
If Resolution 1(b) is passed, 15,403,393 Placement Shares will be excluded in calculating the
Company’s 10% limit in Listing Rule 7.1A, effectively increasing the number of Equity
Securities it can issue without Shareholder approval over the 12-month period following the
issue date.
If Resolution 1(b) is not passed, 15,403,393 Placement Shares will continue to be included in
the Company’s 10% limit under Listing Rule 7.1A, effectively decreasing the number of Equity
Securities the Company can issue or agree to issue without obtaining prior Shareholder
approval, to the extent of 15,403,393 Equity Securities for the 12-month period following the
issue of those Placement Shares.
3.3 Specific information required by Listing Rule 7.5
Pursuant to and in accordance with Listing Rule 7.5, the following information is provided in
relation to the ratification of the issue of the Placement Shares:
(a) The Placement Shares were issued to a range of sophisticated and institutional
investors, none of whom is a related party or a Material Investor of the Company. The
participants in the Placement were identified through a bookbuild process, which
involved the Lead Manager seeking expressions of interest to participate in the
Placement from new and existing contacts of the Company and Lead Manager.
(b) A total of 38,472,223 Placement Shares were issued using the Company’s available
placement capacity in the following proportions:
(i) 23,068,830 Placement Shares issued under Listing Rule 7.1; and
(ii) 15,403,393 Placement Shares issued under Listing Rule 7.1A.
(c) The Placement Shares are fully paid ordinary Shares in the capital of the Company
and rank equally in all respects with the Company’s existing Shares on issue.
(d) The Placement Shares were issued on 17 February 2026 at an issue price of $0.18
each.
(e) The proceeds from the issue of the Placement Shares have been and will continue to
be used towards:
Page 9
(i) progressing ongoing exploration programs at the Marble Bar Gold Project
and Higginsville Lithium Project, including drilling and associated technical
work; and
(ii) general working capital.
(f) There are no other material terms to the issue of the Placement Shares.
(g) A voting exclusion statement is included in the Notice.
3.4 Additional information
Resolution 1(a) and Resolution 1(b) are each separate ordinary resolutions.
The Board recommends that Shareholders vote in favour of Resolution 1(a) and Resolution
1(b).
4. Resolution 2 – Approval to issue Director Placement Shares
4.1 General
The background to the proposed issue of the Director Placement Shares is set out in Section
3.1 above.
The Company has received firm commitments from the Participating Directors to participate in
the Placement on the same terms as unrelated parties, as follows:
Participating Director
Amount committed to the
Placement ($)
Director Placement Shares
Luke Reinehr $20,000 111,111
Graeme Sloan $25,000 138,889
Paul Adams $50,000 277,778
Total $95,000 527,778
Resolution 2(a) to (c) (inclusive) seek Shareholder approval pursuant to Listing Rule 10.11 for
the issue of the Director Placement Shares in the proportions set out above.
4.2 Listing Rule 10.11
Listing Rule 10.11 provides that unless one of the exceptions in Listing Rule 10.12 applies, a
listed company must not issue or agree to issue Equity Securities to any of the following persons
without the approval of Shareholders:
(a) a related party (Listing Rule 10.11.1);
(b) a person who is, or was at any time in the 6 months before the issue or agreement, a
substantial holder (30%+) in the company (Listing Rule 10.11.2);
(c) a person who is, or was at any time in the 6 months before the issue or agreement, a
substantial holder (10%+) in the company and who has nominated a director to the
board of the company pursuant to a relevant agreement which gives them a right or
expectation to do so (Listing Rule 10.11.3);
(d) an associate of a person referred to in Listing Rules 10.11.1 to 10.11.3 (Listing Rule
10.11.4); or
Page 10
(e) a person whose relationship with the company or a person referred to in Listing Rule
10.11.1 or 10.11.4 is such that, in ASX’s opinion, the issue or agreement should be
approved by its shareholders (Listing Rule 10.11.5).
The Participating Directors are related parties of the Company by virtue of being Directors.
Shareholder approval pursuant to Listing Rule 10.11 is therefore required unless an exception
applies. It is the view of the Board that the exceptions set out in Listing Rule 10.12 do not apply
in the current circumstances.
Approval pursuant to Listing Rule 7.1 is not required for the issue of the Director Placement
Shares as approval is being obtained under Listing Rule 10.11. Accordingly, the issue of these
Director Placement Shares to the Participating Directors (or their respective nominee/s) will not
be included in the Company’s 15% placement capacity pursuant to Listing Rule 7.1.
The effect of Shareholders passing Resolution 2(a) to (c) (inclusive) will be to allow the
Company to issue the Director Placement Shares and receive the $95,000 (before costs)
committed by the Participating Directors.
If Resolution 2(a) to (c) (inclusive) are not passed, the Company will not be able to proceed
with the issue of the Director Placement Shares and will not receive the additional funds
committed by the Participating Directors.
Resolution 2(a) to (c) (inclusive) are not conditional on each other and Shareholders may
approve one or all of these Resolutions (in which case, the Director Placement Shares the
subject of the approved Resolution(s) will be issued), even though Shareholders have not
approved all of these Resolutions.
4.3 Specific information required by Listing Rule 10.13
Pursuant to and in accordance with Listing Rule 10.13, the following information is provided in
relation to the proposed issue of the Director Placement Shares:
(a) The Director Placement Shares will be issued to the Participating Directors (or their
respective nominee/s), in the proportions set out in Section 4.1 above.
(b) Each of the Participating Directors fall into the category stipulated by Listing Rule
10.11.1. In the event the Director Placement Shares are issued to a nominee of a
Participating Director, that nominee will fall into the category stipulated by Listing Rule
10.11.4.
(c) A maximum of 527,778 Director Placement Shares will be issued to the Participating
Directors (or their respective nominee/s), in the proportions set out in Section 4.1
above.
(d) The Director Placement Shares will be full paid and rank equally in all respects with
the Company’s existing Shares on issue.
(e) The Director Placement Shares will be issued no later than one (1) month after the
date of the Meeting.
(f) The Director Placement Shares will be issued at a price of $0.18 each, being the
same issue price at which the Placement Shares were issued.
(g) The proceeds from the issue of the Director Placement Shares are intended to be
used in the same manner as the proceeds from the Placement Shares, as set out in
Section 3.3(e) above.
(h) The proposed issue of the Director Placement Shares is not intended to remunerate
or incentivise the Participating Directors.
Page 11
(i) There are no other material terms to the proposed issue of the Director Placement
Shares.
(j) A voting exclusion statement is included in the Notice.
4.4 Section 195 of the Corporations Act
Section 195(1) of the Corporations Act prohibits a director of a public company who has a
material personal interest in a matter that is being considered at a meeting of directors from
being present while the matter is being considered at the meeting or voting on the matter. If
there is not a quorum of directors who are eligible to vote on a matter because of the
operation of section 195(1) of the Corporations Act, one or more directors may call a general
meeting and the general meeting may deal with the matter.
Each of the Participating Directors have a personal interest in the outcome of each of their
respective Resolution under Resolution 2(a) to (c) (inclusive) and, as a result of a quorum of
Directors not being achieved, have exercised their right under section 195(4) of the
Corporations Act to put the issue of the Director Placement Shares to the Participating
Directors to Shareholders to resolve.
4.5 Chapter 2E of the Corporations Act
In accordance with Chapter 2E of the Corporations Act, in order to give a financial benefit to a
related party, the Company must:
(a) obtain Shareholder approval in the manner set out in sections 217 to 227 of the
Corporations Act;
(b) give the benefit within 15 months following such approval,
unless the giving of the financial benefit falls within an exception set out in sections 210 to 216
of the Corporations Act.
The proposed issue of the Director Placement Shares constitutes giving a financial benefit to
related parties of the Company.
The Board considers that Shareholder approval pursuant to Chapter 2E of the Corporations Act
is not required in respect of the issue of the Director Placement Shares because the Director
Placement Shares will be issued on the same terms as those Shares issued to non-related
party participants in the Placement and as such the giving of the financial benefit is on arm’s
length terms.
4.6 Additional information
Resolution 2(a) to (c) (inclusive) are each separate ordinary resolutions.
Simon Coyle, being the only director without a personal interest in the outcome of Resolution
2(a) to (c) (inclusive), recommends that Shareholders vote in favour of Resolution 2(a) to
Resolution 2(c) (inclusive).
5. Resolution 3 – Approval to issue Broker Options
5.1 General
The background to the Placement, including the proposed issue of the Broker Options to the
Lead Manager (or its nominee/s), is set out in Section 3.1 above.
Resolution 3 seeks Shareholder approval pursuant to Listing Rule 7.1 for the issue of the
Broker Options to the Lead Manager (or its nominee/s).
Page 12
5.2 Summary of material terms of the Lead Manager Mandate
The Company entered into a mandate with the Lead Manager for the provision of lead
managerial, broker and bookrunner services in respect of the Placement (Lead Manager
Mandate).
Pursuant to the Lead Manager Mandate, the Company has agreed to pay the Lead Manager
the following fees:
(a) a management fee of 2.0% of the gross amount raised under the Placement;
(b) a selling fee of 4.0% of the gross amount raised under the Placement, excluding
funds raised from the chairman’s list; and
(c) the Broker Options.
The Lead Manager Mandate contains additional provisions, including warranties and
indemnities in respect of the Company, which are considered standard for agreements of this
nature.
5.3 Listing Rule 7.1
A summary of Listing Rule 7.1 is in Section 3.2 above.
The proposed issue of the Broker Options does not fit within any of the exceptions to Listing
Rule 7.1 and therefore requires the approval of Shareholders under Listing Rule 7.1.
If Resolution 3 is passed, the Company will be able to proceed with the issue of the Broker
Options.
If Resolution 3 is not passed, the Company will not be able to proceed with the issue of the
Broker Options and will have to consider alternative commercial means to pay the Lead
Manager for its services, which may include a cash payment equivalent to the value of the
Broker Options.
5.4 Specific information required by Listing Rule 7.3
Pursuant to and in accordance with Listing Rule 7.3, the following information is provided in
relation to the proposed issue of the Broker Options:
(a) The Broker Options will be issued to the Lead Manager (or its nominee/s), none of
whom is a related party or a Material Investor of the Company.
(b) A maximum of 5,000,000 Broker Options will be issued.
(c) The Broker Options will be exercisable at $0.27 each, expire on 1 February 2028 and
will otherwise be subject to the terms and conditions in Schedule 2.
(d) The Broker Options will be issued within 3 months of the date of the Meeting.
(e) The issue price of the Broker Options will be $0.00001 each.
(f) The Broker Options will be issued as partial consideration for the provision of lead
managerial and bookrunner services pursuant to the terms of the Lead Manager
Mandate. Accordingly, only nominal funds of $50 will be raised by the issue of the
Broker Options, which will form part of the Company’s working capital.
(g) A summary of the material terms of the Lead Manager Mandate is in Section 5.2.
(h) A voting exclusion statement is included in the Notice.
Page 13
5.5 Additional information
Resolution 3 is an ordinary resolution.
The Board recommends that Shareholders vote in favour of Resolution 3.
6. Resolution 4 – Ratification of agreement to issue SQM Consideration
Shares
6.1 General
On 25 February 2026, the Company announced that it had entered into a binding terms sheet
with SQM Australia Pty Ltd (ACN 621 414 659) (SQM) to acquire SQM’s 30% beneficial
interest in the DOM’s Hill and Pear Creek Projects located in the Pilbara region of Western
Australia (Acquisition Agreement).
A summary of the material terms of the Acquisition Agreement is in Section 6.2 below.
Resolution 4 seeks Shareholder approval pursuant to Listing Rule 7.4 to ratify the agreement
to issue up to 816,713Shares (SQM Consideration Shares) under the Acquisition
Agreement.
6.2 Summary of Acquisition Agreement
A summary of the material terms of the Acquisition Agreement is set out below:
(a) (Consideration): As consideration pursuant to the Acquisition Agreement, the
Company has agreed to pay SQM (or its nominee/s):
(i) a cash payment of $60,000;
(ii) the Consideration Shares, which will be subject to a 12-month voluntary
escrow period on and from the date of issue; and
(iii) a 1.5% net smelter royalty.
(b) (Condition Precedent): The Acquisition Agreement is conditional on SQM having
obtained from Kalamazoo Resource
Share your feedback
Discover